Brain 17 Vienna

asymptomatic previously untreated brain metastases (166) PROFILE trials progression free survival (systemic vs. intracranial)

Brain metastases in patients with ALK-positive NSCLC

Costa et al 2015, J Clin Oncol; 33 (17): 1881-1888